4//SEC Filing
Schonharting Florian 4
Accession 0001455244-11-000028
CIK 0000827809other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 7:31 PM ET
Size
8.3 KB
Accession
0001455244-11-000028
Insider Transaction Report
Form 4
QLT INC/BCQLTI
Hansen Christian
10% Owner
Transactions
- Sale
Common Shares, no par value
2011-08-29$7.08/sh−200,000$1,416,860→ 7,527,613 total
NB Public Equity K/S
10% Owner
Transactions
- Sale
Common Shares, no par value
2011-08-29$7.08/sh−200,000$1,416,860→ 7,527,613 total
Schonharting Florian
10% Owner
Transactions
- Sale
Common Shares, no par value
2011-08-29$7.08/sh−200,000$1,416,860→ 7,527,613 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.28 inclusive. The Reporting Owners undertake to provide to QLT, Inc., any security holder of QLT, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
- [F3]Christian Hansen and Florian Schonharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Schonharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.
Documents
Issuer
QLT INC/BC
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001360509
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 7:31 PM ET
- Size
- 8.3 KB